Multicenter, Randomized, Controlled, Double-Masked Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The RAINIER Study)
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2018
Price : $35 *
At a glance
- Drugs OC-02 (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Acronyms The RAINIER
- Sponsors Oyster Point Pharmaceuticals
- 26 Oct 2018 Status changed from active, no longer recruiting to completed.
- 05 Sep 2018 Status changed from recruiting to active, no longer recruiting.
- 23 Aug 2018 New trial record